These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dose-dependent melanonychia by mitoxantrone. Reinsberger C; Meuth SG; Wiendl H Mult Scler; 2009 Sep; 15(9):1131-2. PubMed ID: 19570819 [TBL] [Abstract][Full Text] [Related]
7. Nail pigmentation due to hydroxycarbamide. Ceulen RP; Frank J; Poblete-Gutiérrez P Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal melanonychia and pseudo-Hutchinson sign associated with amlodipine. Sladden MJ; Mortimer NJ; Osborne JE Br J Dermatol; 2005 Jul; 153(1):219-20. PubMed ID: 16029363 [No Abstract] [Full Text] [Related]
16. Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy. Khan S; Bolton WK Clin J Am Soc Nephrol; 2014 Jun; 9(6):1001-4. PubMed ID: 24855281 [No Abstract] [Full Text] [Related]
17. Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus. Sifuentes Giraldo WA; Grandal Platero M; de la Puente Bujidos C; Gámir Gámir ML Reumatol Clin; 2013; 9(6):381-2. PubMed ID: 23481508 [No Abstract] [Full Text] [Related]
18. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea. Hernández-Martín A; Ros-Forteza S; de Unamuno P J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924 [TBL] [Abstract][Full Text] [Related]
19. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera. Gropper CA; Don PC; Sadjadi MM Int J Dermatol; 1993 Oct; 32(10):731-3. PubMed ID: 8225715 [No Abstract] [Full Text] [Related]
20. Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CON. van de Logt AE; Wetzels JF Kidney360; 2021 Nov; 2(11):1699-1701. PubMed ID: 35372989 [No Abstract] [Full Text] [Related] [Next] [New Search]